← Back to Search

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics Pilot Study (STOP-PEDS Trial)

N/A
Waitlist Available
Led By Margaret Rosenfeld, MD
Research Sponsored by University of Washington, the Collaborative Health Studies Coordinating Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether it is better to give immediate antibiotics to children with CF who have a pulmonary exacerbation, or to tailor the therapy based on the individual.

Eligible Conditions
  • Cystic Fibrosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Delayed antibiotics
Secondary study objectives
Consent
Day 28 Follow-up
Participant Exacerbations
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Tailored TherapyExperimental Treatment1 Intervention
increased airway clearance alone, with addition of antibiotics for worsening symptoms or failure to improve
Group II: Immediate AntibioticsExperimental Treatment1 Intervention
increased airway clearance plus early initiation of oral antibiotics

Find a Location

Who is running the clinical trial?

University of Washington, the Collaborative Health Studies Coordinating CenterLead Sponsor
6 Previous Clinical Trials
9,934 Total Patients Enrolled
4 Trials studying Cystic Fibrosis
1,046 Patients Enrolled for Cystic Fibrosis
Cystic Fibrosis FoundationOTHER
197 Previous Clinical Trials
37,449 Total Patients Enrolled
190 Trials studying Cystic Fibrosis
34,552 Patients Enrolled for Cystic Fibrosis
Margaret Rosenfeld, MDPrincipal InvestigatorSeattle Children's Hospital, Seattle, WA
2 Previous Clinical Trials
140 Total Patients Enrolled
1 Trials studying Cystic Fibrosis
35 Patients Enrolled for Cystic Fibrosis
Donald B. Sanders, MDPrincipal InvestigatorRiley Children's Hospital, Indianapolis, IN
~24 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top